KCNN3 and brain disorder: KCNN3 genomic variants have been associated with brain disease and SK channels are expressed widely in brain and play a key role in the control of neuronal activity; thus, drugs modulating SK3 activity may be useful to treat neuropsychiatric disorders (Blank et al., 2004).